In an example, a process includes polymerizing a mixture that includes an ethylene monomer, a propylene monomer, and a diene monomer to form an ethylene-propylene-diene (EPDM) terpolymer using ring-opening metathesis polymerization (ROMP). The process further includes chemically reacting the EPDM terpolymer with a norbornene-based phosphinate cross-linking material to form a flame-retardant, cross-linked EPDM rubber.

The present application provides, among other things, compounds and methods for metathesis reactions. In some embodiments, provided compounds promote highly efficient and highly Z-selective metathesis. In some embodiments, provided compounds and methods are particularly useful for producing allyl alcohols. In some embodiments, provided compounds have the structure of formula I. In some embodiments, provided compounds comprise ruthenium, and a ligand bonded to ruthenium through a sulfur atom.

A series of diazirine compounds of formula (I) having utility as photocrosslinkers are disclosed. ##STR00001##
Where, A, L, z, Ar.sub.x and R.sub.y are as defined herein. Also disclosed are the photodefinable compositions containing these compounds.

plasmonic ROM polymer composites optionally comprising a latent catalyst, precursors thereof and uses thereof as a catalyst, are disclosed.

The present disclosure provides enynes, end-functionalized polymers, conjugates, methods of preparation, compositions, kits, and methods of use. The conjugates comprise at least (1) a peptide (e.g., an antibody), protein, nucleoprotein, mucoprotein, lipoprotein, glycoprotein, or polynucleotide; and (2) a polymer comprising a pharmaceutical agent. The conjugates may be useful in delivering (e.g., targeted delivering) the pharmaceutical agent to a subject in need thereof or cell or treating, preventing, or diagnosing a disease.

Described herein, in part, are compositions and methods for processing and curing photopolymer composition based on olefin matathesis. The photopolymer composition comprises a latent ruthenium (Ru) complex, an initiator and at least one polymer precursor. A method for preparing a cured photopolymer composition comprises exposing the photopolymer composition to electromagnetic radiation above a threshold energy to activate the initiator and exposing the photopolymer to electromagnetic radiation below said threshold energy, thereby preparing the cured photopolymer composition.

Materials (e.g., particles, hydrogels) that provide extended release of one or more therapeutic agents are useful platforms for drug delivery. In part, the present invention relates to new triblock (ABC) bottlebrush copolymers which can be used in the formulation of particles and hydrogels for the extended release of therapeutic agents. In certain embodiments, the triblock bottlebrush copolymers, particles, and hydrogels described herein are thermally-responsive and gel at physiological temperature (e.g., upon administration to a subject), providing injectable and/or implantable gels which can be used for extended release drug delivery. The present invention also provides methods for extended release drug delivery, and methods of treating and/or preventing a disease or conditions in a subject, using the inventive copolymers, particles, and hydrogels. In addition, the present invention provides methods of preparing the triblock bottlebrush copolymers described herein.

The present invention, among other things, provides highly syndiotactic poly(dicyclopentadiene) and/or hydrogenated poly(dicyclopentadiene), compositions thereof, and compounds and methods for preparing the same. In some embodiments, a provided compound is a compound of formula I, II or III. In some embodiments, a provided method comprises providing a compound of formula I, II or III.

The present invention provides: a copolymer (A) which is a copolymer obtained by copolymerizing one or plural cycloolefin monomers and one or plural acyclic olefin monomers, or by copolymerizing two or more cycloolefin monomers, wherein a glass transition temperature (Tg) is 100 C. or higher, a refractive index is 1.545 or higher, and an Abbe's number is 50 or larger; a polymer (B) selected from: a ring-opening homopolymer obtained by ring-opening polymerization of only a monomer represented by formula (I), a ring-opening copolymer obtained by ring-opening copolymerization of the monomer represented by formula (I) and a monomer capable of ring-opening copolymerization with the monomer represented by formula (I), a hydrogenated product of the ring-opening homopolymer and a hydrogenated product of the ring-opening copolymer; a forming material containing the copolymer (A) or the polymer (B); and a resin formed article obtained by forming the forming material.

##STR00001##

Medical instrument including a substrate using a fluorine-containing cyclic olefin polymer containing a structural unit represented by General Formula (1), in which the substrate has one surface where the substrate comes into contact with cells, and the substrate is provided with a convex-concave structure on the one surface, a ratio (L1/L2) of a width (L1) between convexities formed by the convex-concave structure and a maximum diameter (L2) of inoculated cells per cell in the cells is 1 to 300, and the cells do not adhere to or attach to the one surface provided with the convex-concave structure and the medical instrument promotes cell proliferation.

##STR00001##

wherein R.sup.1 to R.sup.4 are defined.